Seres Therapeutics Reports Third Quarter 2015 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. IBM
2. PRIM
3. META
4. ABBV
5. NAVN
6. CNC
7. KFY
8. MU
9. DPZ
10. PLTR

Go back to Seres Therapeutics Reports Third Quarter 2015 Financial Results and Provides Business Update

Seres Therapeutics (MCRB) Misses Q3 EPS by 6c

November 10, 2015 8:36 AM EST

Seres Therapeutics (NASDAQ: MCRB) reported Q3 EPS of ($0.38), $0.06 worse than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.

... More